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Strengths and limitations of this study
 ► This will be the first study to develop a list of clinical 
indictors to identify a neuropathic component to low 
back- related leg pain, which will help to inform clini-
cians regarding treatment interventions.
 ► This study will use national and international ex-
perts in neuropathic pain to inform the list of clinical 
indicators.
 ► This study will be reported in line with Conducting 
and Reporting Delphi Studies recommendations.
 ► This study is a mixed method design and thus utilis-
es quantitative and qualitative data.
 ► The views of Delphi panellists may differ from those 
experts who decline participation, and may not fully 
represent experts in the field of interest.
AbStrACt
Introduction Neuropathic low back- related leg pain 
(LBLP) can be a challenge to healthcare providers to 
diagnose and treat. Accurate diagnosis of neuropathic 
pain is fundamental to ensure appropriate intervention 
is given. However, to date there is no gold standard to 
diagnose neuropathic LBLP. A Delphi study will therefore 
be conducted to obtain an expert- derived consensus list 
of clinical indicators to identify a neuropathic component 
to LBLP.
Methods/analysis Included participants will be 
considered experts within the field as measured against 
a predefined eligibility criterion. Through an iterative 
multistage process, participants will rate their agreement 
with a list of clinical indicators and suggest any missing 
clinical indicators during each round. Agreement will 
be measured using a 5- point Likert scale. Descriptive 
statistics will be used to measure agreement; median, IQR 
and percentage of agreement. A priori consensus criteria 
will be defined for each round. Data analysis at the end 
of round three will enable a list of clinical indicators to be 
derived.
Ethics and dissemination Ethical approval was gained 
from the University of Birmingham (ERN_19-1142). On 
completion of the study, findings will be disseminated 
in a peer- reviewed journal and presented at relevant 
conferences.
IntroduCtIon
Neuropathic pain (NP) is defined as pain 
caused by a lesion or disease of the somato-
sensory nervous system.1 NP is a largely 
unmet medical need due to ineffective 
management.2 NP is highly prevalent and has 
been estimated to have a global population 
prevalence of between 6.9% and 10%.3 NP is 
associated with vast economic costs, with total 
annual costs (including direct and indirect 
costs) per patient in Europe ranging from 
£8710 in the UK to €14 446 in Germany.4 
Epidemiological surveys have shown that 
many patients with NP do not receive appro-
priate treatment; a common reason for this 
is misdiagnosis.5 One of the most common 
presentations of NP is found in those with 
low back pain (LBP), which is estimated to 
be at approximately 46.7%.6 Up to two thirds 
of individuals with LBP report concomitant 
leg pain when presenting in primary and 
secondary care services.7 Low back- related 
leg pain (LBLP) compared with LBP alone is 
associated with increased disability, increased 
pain and poorer quality of life.8 9 LBLP is 
generally clinically diagnosed as sciatica 
(lumbar radicular) or referred pain (involving 
non- neural structures); sciatica is considered 
neuropathic in nature whereas referred pain 
is considered nociceptive.7 However, there is 
evidence to suggest the coexistence of both 
pain mechanisms in LBLP,10 and evidence for 
sciatica presenting without NP and referred 
pain presenting with NP.11
According to the National Institute for 
Health and Care Excellence recent guide-
lines, the management of NP differs signifi-
cantly to the management of LBP without 
sciatica.12 Thus the importance of accurate 
diagnosis of NP in relation to LBLP ensures 
that appropriate management is provided. 
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Figure 1 Modified Delphi processes to construct list of 
clinical indicators. NP, neuropathic pain
Identification of patients with NP in LBLP is essential as 
pharmaceutical intervention, if indicated, may improve 
patient outcomes.7 To date, there is no gold standard 
for diagnosing NP.13 Consequently, expert opinion 
consensus- derived lists and a variety of patient- reported 
outcome measures have been developed and used as 
methods to determine the presence of NP in research 
studies.7 14 However, there is no uniformity within the 
literature regarding the best clinical indicators to use 
to identify NP in LBLP. The most common clinical indi-
cators utilised to identify NP in LBLP research include 
the PainDetect,15 The Leeds Assessment of Neuropathic 
Symptoms and Signs16 and Douleur Neuropathique 4 
(DN4).17
A cross- sectional study by Smart et al1818 is the one 
study to identify clinical indicators predictive of the 
presence of peripheral NP in LBP (with or without leg 
pain), consisting of a cluster of two symptoms and one 
sign: ‘pain referred in a dermatomal or cutaneous distri-
bution’, ‘history of nerve injury, pathology or mechan-
ical compromise’ and ‘pain/symptom provocation with 
mechanical/movement tests (eg, active/passive, neuro-
dynamic) that move/load/compress neural tissue’. 
However, there is evidence to refute aspects of this cluster. 
For instance experimental research suggests that remote 
immune- inflammatory mechanisms can contribute to the 
non- dermatomal/cutaneous innervation spread of symp-
toms in response to mild sciatic nerve compression in rat 
models.19 Furthermore, evidence of non- dermatomal/
cutaneous innervation spread of symptoms in both distal 
and proximal entrapment neuropathies have been previ-
ously reported.20 21 This highlights the possibility that pain 
may not always follow a dermatomal/cutaneous innerva-
tion pattern. In addition, an increasing body of literature 
highlights the low diagnostic validity of neurodynamic 
testing which consequently questions its utility as an indi-
cator to detect NP in LBLP.22–24 These findings highlight 
a need for further consideration of the clinical indicators 
used to identify NP in LBLP, as clinical uncertainty exists 
and there is no established gold standard.
objective
To conduct a three round modified Delphi study to 
achieve expert consensus on a list of clinical indicators to 
identify NP in LBLP.
MEthodS
This study will be conducted using a modified Delphi 
method. The Delphi method is an iterative multistage 
process used to achieve expert consensus on a given 
subject.25 Expert consensus- derived criteria obtained 
through a Delphi method have been shown to be an 
effective tool in situations of uncertainty to inform clin-
ical decision making.26 The Delphi method is a low- cost, 
simple procedure which can be used to gain information 
from a large population.27 The Delphi method is anon-
ymous and participants do not directly interact, instead 
they receive feedback from their peers and this mini-
mises the risk of few individuals’ opinions dominating.28 
The anonymity has also been linked to higher response 
rates.29 This Delphi will be conducted online which helps 
to accelerate data collection. Furthermore, geographical 
location provides no barrier to participation in the study 
as it will be conducted electronically.28
This three- round modified Delphi method has been 
designed with guidance from the Conducting and 
Reporting Delphi Studies (CREDES) recommenda-
tions (online supplementary appendix 1). The CREDES 
recommendations are featured on the Equator network 
and are the only reporting guidance recommendations 
for Delphi studies.30 Three rounds of questionnaires 
will be administered anonymously through RedCap 
(https://www. project- redcap. org). All three rounds will 
use a 5- point Likert scale to evaluate the level of agree-
ment. Between rounds one and three, the results will be 
analysed and questionnaires constructed for subsequent 
rounds. Clinical indicators that do not achieve consensus 
will be removed at each stage. Resultant data at the end of 
round three will be brought together to devise a consensus 
derived list of clinical indicators. The stages of the Delphi 
and development of the expert consensus derived list of 
clinical indicators is summarised in figure 1.
Steering committee
The steering committee will be located at the Univer-
sity of Birmingham. The committee will comprise of the 
lead investigator, a MRes student JM, second investigator 
a PhD student TN and three senior academics based 
at the University of Birmingham AR, DF and NH. The 
three senior academics have considerable experience 
of using the Delphi technique as well as quantitative 
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Figure 2 Procedure and timelines for participants in Delphi 
study.
and qualitative research methods, and will ensure study 
quality at each stage.
Participants
Experts will be defined as individuals with a high level 
of knowledge within the area of NP in LBLP which will 
be confirmed against the eligibility criteria outlined 
below. Recruited experts will be expected to develop a 
consensus list which will reflect a high degree of content/
face validity.31 Experts will include musculoskeletal/
pain specialist physiotherapists, allied healthcare profes-
sionals, doctors and academics; all of whom work within 
a pain setting/have a special interest in NP. JM and TN 
will review the profiles of potential participants to decide 
eligibility based on the following criteria:
 ► International research experts who have ≥2 peer- 
reviewed publications relating to NP in LBLP or a 
related topic32.
 ► Working within a pain clinic/musculoskeletal outpa-
tient department for ≥10 years.
Fulfilment of ≥1 criterion will be required for partici-
pant inclusion. There is no clear evidence to support the 
use of a predefined criteria in ensuring expert participant 
recruitment into a Delphi study, but it is consistent with 
the CREDES recommendations as well as criteria used 
in previous Delphi studies.32–34 Also, the use of eligibility 
criteria increases the rigour and transparency of the 
recruitment process and minimises the risk of disputes 
between recruiters.
The number of participants in Delphi studies varies 
considerably and there is no clear indication within the 
literature of what the ideal number is.27 The aim for this 
study will be to recruit a minimum of 30 participants.35 
Furthermore, no upper limit will be set as the greater the 
number of participants the greater the data generation. 
The expectation is that no more than 100 participants will 
be recruited based on a previous similar Delphi study.14
recruitment
A snowballing strategy will be used to identify poten-
tial participants. JM and TN will review authorships of 
published systematic reviews relating to the clinical indi-
cators of NP and identify national and international 
profiles. Experts will be invited to participate in the study 
and also requested to suggest any peers who fit the eligi-
bility criteria.34 Call for expressions of interest will be 
posted on social media for participants to be nominated 
or to self- nominate themselves. Social media platforms 
will be used due to its high- quality healthcare, research 
and academic communities.36
Contacted individuals will receive an email with four 
attached documents. A Participant Information Sheet 
will describe the aims and objectives of the Delphi, justi-
fication for the study, eligibility requirements for experts, 
stages involved in the Delphi process, timeframe for 
each stage, assurance on anonymity and the withdrawal 
process. The second document will be a consent form, the 
third a conflict of interest form and the final document 
will be a participant information form for participants to 
detail: age, gender, country of origin, country of current 
employment, highest qualification, occupation, profes-
sional background/credentials and working period in 
NP in LBLP/related field.32 Return of the consent form 
and conflict of interest and participant information form 
signifies agreement to participate. Recruiters will collate/
review returned information and email individuals to 
confirm participation in the study.
Ethical considerations/quality assurance
Eligible participants will be required to return a consent 
form and conflict of interest form. Participants will be 
advised at the start of the study of the withdrawal process 
should they need it. ID codes will be used instead of 
personal information to ensure participants remain 
anonymous throughout the process.
The data obtained in the study will be stored in a pass-
word encrypted electronic device which will only be acces-
sible to the researchers involved in the study. Anonymity 
will be ensured throughout the study. Quality assurance 
will be achieved through three senior academics (AR, NH, 
DF) who are part of the steering committee. They share 
vast research methods experience, including the use of 
the Delphi method, therefore the use of their expertise 
in guiding/providing supervision to the lead investigator 
(JM) will ensure quality is maintained.
Procedure
Figure 2 details the procedure and timeline for the study. 
Prior to the start of the study, a pre- notification period of 
6 weeks will be allocated to recruit participants.
Round 1
In the first- round participants will be invited to provide 
their level of agreement with the list of clinical indica-
tors suggested by Smart et al1414 to identify peripheral NP 
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(online supplementary appendix 2), for the purpose of 
this study in relation to identifying NP in LBLP. Level 
of agreement will be sought using a 5- point Likert scale 
(5=Strongly agree, 4=Agree, 3=No opinion, 2=Disagree, 
1=Strongly disagree). A 5- point Likert scale will be used as 
any number less than 5 in a Likert scale has been demon-
strated to compromise reliability and validity.37 Second, 
through open questions, participants will be invited to 
identify any missing clinical indicators. Participants will 
be invited to explain their reasons for their ratings and 
missing clinical indicators in a free text box. The use 
of open- ended questions allows participant freedom to 
volunteer any clinical indicators considered relevant, and 
for a richness in the qualitative data collected.26
Participants will be given 1 month to complete round 1. 
Reminder emails will be sent to non- responders at weeks 
1 and 3, and in this email the withdrawal process will be 
highlighted if participants are unable to continue with 
the study.38 Only those participants who complete round 
1 will be invited to round 2, in line with previous Delphi 
studies.34 39
Round 2
Participants will be issued with the second questionnaire 
constructed from the results of round 1. Participants will 
again be invited to provide level of agreement/disagree-
ment using the Likert scale for clinical indicators. Partic-
ipants will be invited to identify any missing clinical 
indicators in the format of an open- ended question. 
Furthermore, participants will also be given the opportu-
nity to explain the reason for their ratings and addition of 
any further clinical indicators.
Participants will be given 1 month to complete round 2. 
Reminder emails will be sent to non- responders at weeks 
1 and 3.38 Only those participants who complete round 2 
will be invited to round 3.
Round 3
The questionnaire for round 3 will be constructed using 
the clinical indicators which achieved consensus and 
any additional information gained from the open- ended 
question from round 2. In round 3, participants will be 
issued with the third questionnaire constructed from the 
results of round 2. Participants will be asked to re- rate 
their level of agreement with the clinical indicators, 
presented in graphical format as per round 2. Partici-
pants will also be invited to rank each clinical indicator 
for their importance, from highest to lowest. Feedback 
on round 3 will not be provided to the participants. 
Response data will then be re- analysed for levels of agree-
ment and consensus.40 The steering committee will then 
use the results to identify a consensus derived list of clin-
ical indicators.
data collection
Response data will be collected and quantitative data will 
be statistically analysed using SPSS V.25.0 (IBM Corp.) 
and qualitative data from the open- ended questions will 
be inputted into summary tables in a word document 
for content analysis.41 Each round will take 4 weeks with 
2 weeks after each round allocated for data analysis and 
formulation of the subsequent questionnaire.38
data analysis
Round 1
Level of agreement with Smart et al’s14 list will be measured 
using the Likert scale. Descriptive statistics including 
median, IQR and percentage of agreement will be gath-
ered using data from each participant.32
Responses to open questions will be reviewed by JM and 
TN and content analysis will be carried out.41 Results of 
content analysis will be brought back to the steering group 
to ensure quality is maintained, also any disagreements in 
content analysis will be presented to the steering group. 
Content analysis is typically used to identify major themes 
in response to qualitative data.14 The questionnaire for 
round 2 will be constructed using the clinical indicators 
which achieved consensus from Smart et al’s14 list as well 
as using the missing indicators identified by participants 
in the open- ended aspect of the questionnaire.
Round 1 criteria for consensus:
 ► Median value of participants' Likert scale data ≥3.
 ► Percentage of agreement ≥50%.32
Round 2
Results from round 1 will be presented in a graphical 
format, with each criterion presented as a bar chart. Each 
bar chart will show the number and percentage of respon-
dents indicating level of agreement/disagreement. 
Furthermore, a narrative summary will be presented in 
round 2 of the findings from round 1’s open ended ques-
tion section. This will provide participants with feedback 
from round 1.
The Likert scale will be used to assess agreement/
disagreement with round 2 clinical indicators. Further 
content analysis will be conducted from the open- ended 
free text boxes. The round 3 questionnaire will be 
constructed using the same method as round 1.
Round 2 criteria for consensus:
 ► Median value of participants Likert scale data ≥3.5.
 ► IQR value of participants' Likert scale data ≤2.
 ► Percentage of agreement ≥60%.32
Round 3
As per round 2, graphical depiction of round 2 findings 
and narrative summaries will be presented to partic-
ipants. Participants will use the Likert scale again to 
suggest agreement/disagreement with round 3 clinical 
indicators. Participants will also rank each clinical indi-
cator from highest to lowest with respect to importance.
Round 3 criteria for consensus:
 ► Median value of participants' Likert scale data ≥4.
 ► IQR value of participants Likert scale data ≤3.
 ► Percentage of agreement ≥70%.32
Agreement between participants will also be evaluated 
across all clinical indicators using Kendall’s W coefficient 
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of concordance,29 statistical significance will be set at 
p<0.05.
data management
All participant information and feedback will be securely 
stored on a password- protected computer throughout the 
duration of the study. Only members of the research team 
will be able to access the information. After completion 
of the Delphi study, all data will be kept securely for 10 
years in the School of Sport, Exercise and Rehabilitation 
Sciences, University of Birmingham before being securely 
destroyed, in accordance with University guidelines.
Patient and public involvement
Information from patients and the public has informed 
the conception and requirement for this Delphi study as 
part of an existing programme of research that is centred 
on lumbar spinal surgery for LBLP and patient outcome.
dissemination plan
This protocol will be submitted to an open access peer- 
reviewed journal. On completion the study findings will 
be disseminated in a peer- reviewed journal and presented 
at relevant conferences.
dISCuSSIon
The results from this study will assist both clinicians and 
researchers in establishing a clear reference standard 
for diagnosing NP in LBLP. By establishing a uniformly 
recognised reference standard, timely and accurate diag-
nosis to inform precision management of patients with 
NP in LBLP will be possible. In turn, timely and accurate 
diagnosis will enable an improved prognosis and reduce 
the risk of patients developing chronicity. It will be 
possible to use the list of clinical indicators derived from 
this study in combination with guidelines12 to further 
inform clinicians regarding the identification of NP in 
LBLP, thus affording greater confidence in their clinical 
judgement. The results from this study will provide the 
first list of clinical indicators specific to identifying NP 
in LBLP, and therefore will serve a need both clinically 
and within the contemporary literature to inform further 
research.
ConCluSIon
There is uncertainty within the literature when consid-
ering the clinical indicators associated with identifying 
NP in LBLP. In order to ascertain a consensus derived 
set of clinical indicators, a modified Delphi study has 
been designed. The clinical implications of this study will 
aid clinicians in identifying a neuropathic component 
to LBLP through a list of clinical indicators. Assisting in 
accurate diagnosis will ensure that appropriate treatment 
is carried out.
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